Terms: = Sarcomas AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
17 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
3. The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer.
Chen H; Huang D; Lin G; Yang X; Zhuo M; Chi Y; Zhai X; Jia B; Wang J; Wang Y; Li J; An T; Wu M; Wang Z; Zhao J
Cancer Med; 2022 Oct; 11(19):3581-3592. PubMed ID: 35394121
[TBL] [Abstract] [Full Text] [Related]
4. Sotorasib for Lung Cancers with
Skoulidis F; Li BT; Dy GK; Price TJ; Falchook GS; Wolf J; Italiano A; Schuler M; Borghaei H; Barlesi F; Kato T; Curioni-Fontecedro A; Sacher A; Spira A; Ramalingam SS; Takahashi T; Besse B; Anderson A; Ang A; Tran Q; Mather O; Henary H; Ngarmchamnanrith G; Friberg G; Velcheti V; Govindan R
N Engl J Med; 2021 Jun; 384(25):2371-2381. PubMed ID: 34096690
[TBL] [Abstract] [Full Text] [Related]
5. If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for
Köhler J; Jänne PA
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809660
[TBL] [Abstract] [Full Text] [Related]
6. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Dudnik E; Moskovitz M; Rottenberg Y; Lobachov A; Mandelboim R; Shochat T; Urban D; Wollner M; Nechushtan H; Rotem O; Zer A; Daher S; Bar J;
Oncoimmunology; 2021 Jan; 10(1):1865653. PubMed ID: 33552685
[TBL] [Abstract] [Full Text] [Related]
7. Genetic heterogeneity and predictive biomarker for pulmonary sarcomatoid carcinomas.
Qin J; Chen B; Li C; Yan J; Lu H
Cancer Genet; 2021 Jan; 250-251():12-19. PubMed ID: 33217678
[TBL] [Abstract] [Full Text] [Related]
8. Targeting
Uras IZ; Moll HP; Casanova E
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560574
[TBL] [Abstract] [Full Text] [Related]
9. [Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma].
Liang Y; Hou H; Jiang M; Zhang C; Liu D; Zhang X
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):239-246. PubMed ID: 32316711
[TBL] [Abstract] [Full Text] [Related]
10. lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation.
Han Y; Feng H; Sun J; Liang X; Wang Z; Xing W; Dai Q; Yang Y; Han A; Wei Z; Bi Q; Ji H; Kang T; Zou W
J Clin Invest; 2019 May; 129(5):1895-1909. PubMed ID: 30830877
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
[TBL] [Abstract] [Full Text] [Related]
12. Pencil Beam Scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of Patients Treated at the Paul Scherrer Institute.
Weber DC; Ares C; Albertini F; Frei-Welte M; Niggli FK; Schneider R; Lomax AJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1731-6. PubMed ID: 26701148
[TBL] [Abstract] [Full Text] [Related]
13. Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.
Liu X; Jia Y; Stoopler MB; Shen Y; Cheng H; Chen J; Mansukhani M; Koul S; Halmos B; Borczuk AC
J Clin Oncol; 2016 Mar; 34(8):794-802. PubMed ID: 26215952
[TBL] [Abstract] [Full Text] [Related]
14. lkb1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT.
Kaufman JM; Amann JM; Park K; Arasada RR; Li H; Shyr Y; Carbone DP
J Thorac Oncol; 2014 Jun; 9(6):794-804. PubMed ID: 24828662
[TBL] [Abstract] [Full Text] [Related]
15. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
16. Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).
Reungwetwattana T; Weroha SJ; Molina JR
Clin Lung Cancer; 2012 Jul; 13(4):252-66. PubMed ID: 22154278
[TBL] [Abstract] [Full Text] [Related]
17. lkb1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma.
Takeda S; Iwai A; Nakashima M; Fujikura D; Chiba S; Li HM; Uehara J; Kawaguchi S; Kaya M; Nagoya S; Wada T; Yuan J; Rayter S; Ashworth A; Reed JC; Yamashita T; Uede T; Miyazaki T
Anticancer Res; 2007; 27(2):761-8. PubMed ID: 17465200
[TBL] [Abstract] [Full Text] [Related]
